Clinical Trial Update: Study on the Safe Dosage and Therapeutic Effect of the Drug YY2201 Tablets on Patients With Advanced Cancer [EARLY_Phase 1]

View source ↗

Summary

An early-phase (Phase 1) study to evaluate the safe dosage and potential therapeutic effect of YY2201 tablets in patients with cancer, with the trial status lis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• YY2201 tablets (YY2201)

Snippet

Sponsor: Jiangsu YaYao Biotechnology Co., Ltd. | Conditions: Advanced Solid Tumors | EARLY_Phase 1 | Status: NOT_YET_RECRUITING